627 related articles for article (PubMed ID: 9727917)
1. Insulin analog lispro decreases insulin resistance and improves glycemic control in an obese patient with insulin-requiring type 2 diabetes.
Darmon P; Curtillet C; Boullu S; Laugier A; Dutour A; Oliver C
Diabetes Care; 1998 Sep; 21(9):1575. PubMed ID: 9727917
[No Abstract] [Full Text] [Related]
2. Pharmacodynamics of insulin Lispro in 2 patients with type II diabetes mellitus.
Jehle PM; Fussgänger RD; Seibold A; Lüttke B; Böhm BO
Int J Clin Pharmacol Ther; 1996 Nov; 34(11):498-503. PubMed ID: 8937933
[TBL] [Abstract][Full Text] [Related]
3. A comparison of preprandial insulin glulisine versus insulin lispro in people with Type 2 diabetes over a 12-h period.
Luzio S; Peter R; Dunseath GJ; Mustafa L; Owens DR
Diabetes Res Clin Pract; 2008 Feb; 79(2):269-75. PubMed ID: 18164094
[TBL] [Abstract][Full Text] [Related]
4. Insulin lispro: new preparation. Faster acting.
Prescrire Int; 1998 Jun; 7(35):67-8. PubMed ID: 10342918
[TBL] [Abstract][Full Text] [Related]
5. A comparative study of insulin lispro and human regular insulin in patients with type 2 diabetes mellitus and secondary failure of oral hypoglycemic agents.
Ross SA; Zinman B; Campos RV; Strack T;
Clin Invest Med; 2001 Dec; 24(6):292-8. PubMed ID: 11767232
[TBL] [Abstract][Full Text] [Related]
6. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
Caballero AE
J Diabetes Complications; 2009; 23(2):143-52. PubMed ID: 18413192
[TBL] [Abstract][Full Text] [Related]
7. Premeal insulin lispro plus bedtime NPH or twice-daily NPH in patients with type 2 diabetes: acute postprandial and chronic effects on glycemic control and cardiovascular risk factors.
Ceriello A; Del Prato S; Bue-Valleskey J; Beattie S; Gates J; de la Peña A; Malone J
J Diabetes Complications; 2007; 21(1):20-7. PubMed ID: 17189870
[TBL] [Abstract][Full Text] [Related]
8. A single-center, randomized, double-blind, three-way crossover study examining postchallenge glucose responses to human insulin 70/30 and insulin lispro fixed mixtures 75/25 and 50/50 in patients with type 2 diabetes mellitus.
Schwartz S; Zagar AJ; Althouse SK; Pinaire JA; Holcombe JH
Clin Ther; 2006 Oct; 28(10):1649-57. PubMed ID: 17157120
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.
Yki-Järvinen H
Diabetes Metab Res Rev; 2002; 18 Suppl 3():S77-81. PubMed ID: 12324990
[TBL] [Abstract][Full Text] [Related]
10. [Lispro mixed insulins in type 2 diabetes. Preventing postprandial insulin rise].
MMW Fortschr Med; 2000 Jul; 142(28-29):58-9. PubMed ID: 10959169
[No Abstract] [Full Text] [Related]
11. How well do rapid-acting insulins work in obese individuals?
Barnett AH
Diabetes Obes Metab; 2006 Jul; 8(4):388-95. PubMed ID: 16776745
[TBL] [Abstract][Full Text] [Related]
12. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
Catargi B; Breilh D; Roger P; Tabarin A
Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
[TBL] [Abstract][Full Text] [Related]
13. [New methods in insulin treatment].
Neuwirth G
Orv Hetil; 2005 Jan; 146(3):111-6. PubMed ID: 15693442
[TBL] [Abstract][Full Text] [Related]
14. [25 years of diabetic treatment by oral hypoglycemic agents: successes and failures].
Tattersall RB
Journ Annu Diabetol Hotel Dieu; 1984; ():183-91. PubMed ID: 6443219
[No Abstract] [Full Text] [Related]
15. Biphasic insulin aspart 30 treatment improves glycemic control among patients with type 2 diabetes in Saudi Arabia and the Gulf region.
Ayad NM; Fattah WA; Bakry H
Saudi Med J; 2008 Jun; 29(6):919-20. PubMed ID: 18521482
[No Abstract] [Full Text] [Related]
16. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
Bode BW
Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
[TBL] [Abstract][Full Text] [Related]
17. [Combination treatment with insulin and metformin in type 2 diabetes. Improves glycemic control and prevents weight gain].
Hermann LS; Melander A
Lakartidningen; 1999 Dec; 96(50):5616-9. PubMed ID: 10643226
[TBL] [Abstract][Full Text] [Related]
18. Optimizing glycemic control with insulin glargine.
Williams JB
Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
[No Abstract] [Full Text] [Related]
19. Insulin detemir--a new basal insulin analog.
Goldman-Levine JD; Lee KW
Ann Pharmacother; 2005 Mar; 39(3):502-7. PubMed ID: 15657117
[TBL] [Abstract][Full Text] [Related]
20. Preprandial combination of lispro and NPH insulin improves overall blood glucose control in type 1 diabetic patients: a multicenter randomized crossover trial.
Annuzzi G; Del Prato S; Arcari R; Bellomo Damato A; Benzi L; Bruttomesso D; Calderini MC; Coscelli C; Fedele D; Galluzzo A; Giordano M; Giorgino R; Lapolla A; Orsini P; Pagano G; Santoro D; Riccardi G
Nutr Metab Cardiovasc Dis; 2001 Jun; 11(3):168-75. PubMed ID: 11590992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
